Still Bracing for the Surge in Advanced Cancer Cases
The predicted wave of late-stage cancers is taking longer to materialize than we expected.
Cancer Moonshot 2.0: Three Big Questions to Track
Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.
Hitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
Top Takeaways from the 2021 ASCO Annual Meeting
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
How Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.
Creating a "Culture of Yes" in Prior Authorization
Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.
Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus
Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.
Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions
Dr. Hertler, CMO at New Century Health, shares his thoughts and perspectives on the future of CAR T-cell therapy and the recent CMS announcements.
Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology
Dr. Hertler, Chief Medical Officer at New Century Health, and others describe the potential of big data and predictive analytics to improve clinical risk stratification for cancer patients.
Cancer Care Costs Everyone Too Much. Here's How We Fix It.
Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.
- Loading More...